The Last of Us zombie fungus hijacked minds even as early as dinosaur era, scientists find
In the real world, fungi belonging to the Ophiocordyceps genus infect ants and cause them to behave strangely.
The fungi force their ant hosts to scale a plant to one of its tallest branches and clamp their jaws tightly onto a leaf.
As the ant remains locked onto the leaf, the fungus slowly consumes the insect's tissues, growing and finally scattering spores down onto the forest floor from the height to restart the cycle afresh with new ant victims.
The fungus is known to reprogramme the instincts of its insect hosts for climbing, gripping, and walking to seek ideal conditions for its own reproduction.
Now, researchers have found remains of early species of this genus trapped in nearly 100-million-year-old fossilised plant sap.
The study, published in the journal Proceedings of the Royal Society B: Biological Sciences, reveals early changes and host shifts undergone by the fungi that shaped their evolution.
These findings are some of the oldest direct evidence of parasitic relationships between fungi and insects, say researchers, including those from Chinese Academy of Sciences.
The origins of such parasitic behaviour have been difficult to trace since the soft nature of fungal tissues causes them to rarely fossilise.
Researchers have now identified two fungal species preserved in 99-million-year-old amber from northern Myanmar.
'Here, we report two new fungi, Paleoophiocordyceps gerontoformicae and Paleoophiocordyceps ironomyiae from mid-Cretaceous Kachin amber (approx. 99 million years old),' scientists wrote in the study.
One of these species, named P. gerontoformicae, occurred along with an infected ant pupa encased in amber dated to about 99 million years ago.
Scientists found that the structural features of this ancient parasitic fungus match those of modern-day Ophiocordyceps species.
By comparing the traits of this ancient fungus to those of other known extinct fungi, researchers say Ophiocordyceps likely emerged about 133.25 million years ago, earlier than previously proposed estimates of about 100 million years.
This was during the Early Cretaceous when dinosaurs roamed the Earth, scientists say.
'These fossils are among the oldest fossil records of animal-pathogenic fungi,' they wrote.
Researchers suspect the fungal genus initially parasitised beetles before undergoing host shifts to infect ants.
This shift was likely related to the increase in diversity and abundance of moths and ants during this period, scientists say.
The latest findings not only document some of the oldest evidence of insect-pathogenic fungi, but also provide new insights into the coevolution between fungi and host insects.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
How common cough syrup could help Parkinson's patients
A new study suggests that Ambroxol, a common cough syrup, may slow the progression of dementia in patients with Parkinson's disease. The year-long clinical trial involving 55 participants found Ambroxol to be safe, well-tolerated, and capable of reaching therapeutic levels in the brain. Participants receiving Ambroxol showed stable neuropsychiatric symptoms, unlike the placebo group, where symptoms worsened, and those with high-risk genetic variants showed improved cognitive performance. The drug appears to protect the brain from deterioration, as indicated by stable levels of the brain damage marker GFAP in the Ambroxol group compared to an increase in the placebo group. While Ambroxol is widely used in Europe for respiratory conditions, it remains unapproved for any use in the United States or Canada, with researchers hoping for larger trials to confirm its effectiveness.
The Independent
2 hours ago
- The Independent
Remains of British man identified 12 years after death thanks to new technology
The remains of a British man who was found dead in Arizona 12 years ago have been identified thanks to new DNA technology, researchers have said. Michael Hill, 75, died in February 2013 whilst visiting a friend in the United States. Having gone to his friend's home with no belongings other than his clothes, and without close relatives to identify him, Mr Hill remained known as the ' Maricopa County John Doe 2013' for more than a decade after his death. But researchers from the UK and US managed to restore Mr Hill's identity using a new method called Investigative Genetic Genealogy (IGG), which combines DNA analysis with genealogical searches – making him the first UK citizen to be identified through this technique. The solving of Mr Hill's case has been hailed as 'a historic milestone' which could pave the way for a wider use of IGG tools in the UK, potentially leading to more unsolved cases being closed. Dr Craig Paterson, who led the work from Sheffield Hallam University, said: 'It is a privilege to see the team solve this case and to restore Michael's name and identity. 'This case proves that IGG can be used in the UK to identify distant relatives and generate leads in cases that have remained unsolved using other investigative techniques. 'There are lots more unsolved cases in the UK where IGG can be used and we will continue to work with our partners and students to ensure that as many cases as possible benefit from this expertise.' The technology can help investigators identify distant relatives of a subject, whereas regular DNA testing usually identifies close family members, Dr Paterson explained. It relies on the millions of members of the public who have taken consumer DNA tests and carried out genetic genealogical searches on platforms such as FamilyTreeDNA and GEDmatch, said David Gurney, director of the Investigative Genetic Genealogy Centre at Ramapo College in New Jersey. The investigation of Mr Hill's case was led by researchers and students from Sheffield Hallam University, the Ramapo College Investigative Genetic Genealogy Centre, and Silverwell Research in London. The team gathered information the police and coroner's officer in Arizona held about Mr Hill, and the team found that Mr Hill had left his friend's house on the day he died, and returned four hours later complaining that he did not feel well. He laid down in a guest bedroom but a short time after began to convulse and went unresponsive. The friend called 911 and emergency service personnel responded to the scene and death was pronounced at that location. The friend Mr Hill visited in the Phoenix area provided a name, Michael Sydney Hill, and date of birth to the authorities. But this information alone could not be used to confirm Hill's identity. Traditional means of identification employed by Maricopa County Office of the Medical Examiner (MCOME) also did not yield a positive result. There was no identification on his person, and he had no siblings, children, or close relatives to contact and provide a positive identification. 'He was still connected to parts of the family – but there was just a loss of contact,' Dr Paterson said. 'It happens a lot more than you would think.' The case remained cold for more than a decade until the team managed to trace a distant cousin of Mr Hill using DNA taken from his body, combined with genealogical analysis. The relative provided a DNA test and Michael Hill's identity was finally confirmed. 'He was born in 1937 so finding a living relative was difficult,' Dr Paterson said. 'We are happy that there was closure. 'That's the aim – it's to take away that uncertainty.' IGG technology has been mainly used in the United States, Canada, and Australia – but researchers hope to increase its use in the UK. Cairenn Binder, director of the IGG Certificate Programme at Ramapo College, said: 'Investigative genetic genealogy was integral to solving the case of Mr Hill because as an unidentified person with only a lead on a possible name and no next of kin, genetic genealogy research was required to restore his identity. 'Advanced DNA testing and shared DNA with his distant relatives allowed investigators to confirm his identity and memorialize him after more than twelve years as a John Doe. 'This case is a historic milestone for the implementation of IGG in the UK, as Mr Hill is the first UK citizen to be identified with IGG research.'
Reuters
3 hours ago
- Reuters
China's Innogen expects to complete weight-loss drug trials next year
SHANGHAI, July 1 (Reuters) - Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next year, its CEO said on Tuesday, the latest Chinese company to join the race to develop obesity treatments. Chinese companies are rushing to develop drugs belonging to the GLP-1 class of medications for weight loss and related conditions as the patent of Novo Nordisk's ( opens new tab semaglutide, a key active ingredient in its best-selling Ozempic and Wegovy drugs, is due to end in early 2026 in China. "I think the Phase IIB will be out by the end of this year, then Phase III will be (finished) by next year,' Innogen CEO Wang Qinghua told Reuters in an interview about the company's experimental drug candidate. Initial results from an early trial, published in June, opens new tab, showed people on the experimental efsubaglutide alfa injection lost about 7% of their body weight after four weeks. By comparison, large-scale trials over a longer period for Novo's weight-loss drug Wegovy helped people lose an average 15% of their body weight, according to its clinical trial data. Wang said the efficacy in Innogen's experimental injection was not fully visible in the firm's drug study because of the short evaluation time, adding the company expects to get more significant weight reduction as it continues with more studies. Chinese regulators have already approved the Shanghai-based company's self-developed efsubaglutide alfa as a once-weekly injection for the control of Type 2 diabetes in January. Yurou Zheng, an analyst at Morningstar, said the near-term challenge for weight-loss drugs in China would be potential price competition, as more drugs are coming online. "I think many users are more likely to pivot to cheaper options if the efficacy profiles are similar or even slightly less superior as long as they are well within a few percentage points," he said in a note. On Friday, Chinese drugmaker Innovent Biologics ( opens new tab became the latest local company entering the increasingly crowded weight-loss drug market, saying its treatment mazdutide, which is licensed from Eli Lilly (LLY.N), opens new tab, was approved by the country's regulators. The Suzhou-based firm said in June that a Phase III trial showed that after 24 weeks of treatment, 6 mg of mazdutide led to about an 8% change in body weight from baseline. Underscoring growing competitive pressure in China, India's Biocon ( opens new tab dropped plans to commercialise its weight loss drugs in China, a senior executive told Reuters last week.
